Board of Directors
Horst G. Zerbe, Ph.D., CEO, IntelGenx Corp.
J. Bernard Boudreau, QC, PC, has a distinguished record as a lawyer, businessman and public figure. He founded and served as the senior partner a law firm in Nova Scotia and was appointed Queen’s Counsel in 1985. He was first elected to the provincial legislature of Nova Scotia in 1988, where he served in various senior cabinet positions including Minister of Finance, and Minister of Health.
In 1999, the Prime Minister of Canada appointed Mr. Boudreau to the positions of Leader of the Government in the Senate of Canada, and the federal Minister responsible for Nova Scotia. The legislative highlight of his career in the Senate came when he led the fight in that Chamber to pass the Clarity Act, working in close cooperation with the Honorable Stéphane Dion and Prime Minister Chrétien.
In 2001 he resumed his private career as President and CEO of Radcliffe Consulting and Investment Ltd. in Halifax, Nova Scotia. In March 2001 he was appointed a Director of Export Development Canada (“EDC”), serving as Chairman of the Pension and Human Resource Committees of that Board. He also serves on the Board of Directors of a number of other public and private corporations. Most recently he has agreed to serve as Chair of the Board of Directors of the Eman Bank of Canada.
Bernd J. Melchers, business economist, is a 30-year veteran of the pharmaceutical and health care industry with extensive experience in corporate financial management. Most recently he was Managing Director of 3M Dyneon Holding GmbH, Germany, and Global Chief Financial Officer of the world wide operating 3M Dyneon Group, a subsidiary of 3M Corporation headquartered in Minnesota. Previously, he served as the European Controller of 3M Medical Markets at the 3M Europe Headquarter located in Brussels, Belgium. Prior to this he held various senior Financial Manager positions at the Medical-Surgical Division of 3M in St. Paul, Minnesota, at 3M Health Care Products, Germany, and at 3M Pharmaceutical Products, Germany.
Ian Troup, B.Sc. has more than 40 years of experience in the pharmaceutical industry, most recently serving as President and Chief Operating Officer of Upsher-Smith Laboratories, a privately held generic pharmaceutical company, prior to which he was President of Schwarz Pharma USA. He is currently an active board member of several Minneapolis-based businesses including Vital Medix, an early stage drug development company, Medisyn Technologies, a privately funded corporation involved in computer based topological drug design, and TwinWest PAC, a political action committee helping Minnesota businesses gain local, state and federal access to political officials.